BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18174740)

  • 1. Mortality and reduced growth hormone secretion.
    Stochholm K; Christiansen J; Laursen T; Gravholt CH
    Horm Res; 2007; 68 Suppl 5():173-6. PubMed ID: 18174740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic abnormalities in growth hormone deficiency.
    Lanes R
    Pediatr Endocrinol Rev; 2004 Dec; 2(2):209-15. PubMed ID: 16429108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
    Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
    Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the adult growth hormone deficiency syndrome: directions for future research.
    Hoffman AR
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():48-52. PubMed ID: 16039888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal prorenin processing in growth hormone deficiency.
    Gordon MS; Caston-Balderrama AL; Gordon MB
    Growth Horm IGF Res; 2005 Aug; 15(4):251-5. PubMed ID: 15967698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
    Scaroni C; Ceccato F; Rizzati S; Mantero F
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of quality of life in patients with growth hormone deficiency.
    Webb SM
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.
    Kołtowska-Haggstrom M; Hennessy S; Mattsson AF; Monson JP; Kind P
    Horm Res; 2005; 64(1):46-54. PubMed ID: 16103683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates in growth hormone treatment and mortality.
    Sherlock M; Stewart PM
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):314-20. PubMed ID: 23807603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult growth hormone deficiency (GHD): an established diagnosis?
    Attanasio AF
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):27-32. PubMed ID: 19020382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
    Chung TT; Evanson J; Walker D; Akker SA; Besser GM; Monson JP; Grossman AB; Drake WM
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):965-9. PubMed ID: 18031317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopituitarism and mortality in pituitary adenoma.
    Lindholm J; Nielsen EH; Bjerre P; Christiansen JS; Hagen C; Juul S; Jørgensen J; Kruse A; Laurberg P; Stochholm K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):51-8. PubMed ID: 16817819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
    Arita K; Hirano H; Tominaga A; Kurisu K
    Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients.
    Mills JL; Schonberger LB; Wysowski DK; Brown P; Durako SJ; Cox C; Kong F; Fradkin JE
    J Pediatr; 2004 Apr; 144(4):430-6. PubMed ID: 15069388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved screening for growth hormone deficiency using logical analysis data.
    Lemaire P; Brauner N; Hammer P; Trivin C; Souberbielle JC; Brauner R
    Med Sci Monit; 2009 Jan; 15(1):MT5-10. PubMed ID: 19114977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of current growth hormone treatments and future therapies.
    Ross R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):48-51. PubMed ID: 19020386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.